Drug Development Technology is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X

Voyager doses first patient in Phase II trial of VY-AADC

A Lewy body (stained brown) in a brain cell of the substantia nigra in Parkinson’s disease. Credit: Marvin 101.

  • Voyager Therapeutics

Go Top